Michael Peng

Michael Peng is a seasoned epidemiologist currently serving as the Senior Director of Epidemiology RWE Oncology Early Development at Gilead Sciences since January 2023. Previously, Michael worked at Bristol Myers Squibb as the Lead Epidemiologist, focusing on epidemiology support for hematology products and post-marketing surveillance. With substantial experience in pharmacoepidemiogical research, Michael held senior roles at Celgene and Roche, contributing to study design, signal detection, and manuscript publication. Michael's career began as an Epidemiologist at Decision Resources and included positions at Cardinal Health, where responsibilities encompassed outcomes research and project management. Michael earned a PhD in Epidemiology from the University of Michigan, an MPH in Epidemiology from Yale School of Medicine, and a BS in Microbiology from the University of Rochester.